In silico and in vitro antileishmanial effects of gamma-terpinene: Multifunctional modes of action.
Antioxidant activities
Gamma-terpinene
Gene expression
Leishmania major
ROS
Journal
Chemico-biological interactions
ISSN: 1872-7786
Titre abrégé: Chem Biol Interact
Pays: Ireland
ID NLM: 0227276
Informations de publication
Date de publication:
01 Jul 2022
01 Jul 2022
Historique:
received:
25
01
2022
revised:
31
03
2022
accepted:
20
04
2022
pubmed:
27
4
2022
medline:
31
5
2022
entrez:
26
4
2022
Statut:
ppublish
Résumé
Leishmaniasis denotes a significant health challenge worldwide with no ultimate treatment. The current study investigated the biological effects of gamma-terpinene (GT) on Leishmania major in putative antileishmanial action, cytotoxicity, apoptosis induction, gene expression alteration, antioxidant activity, hemolysis, and ROS generation. GT and meglumine antimoniate (MA) were probed alone and in combination (GT/MA) for their anti-leishmanial potentials using the MTT biochemical colorimetric assay and a model macrophage cell. In addition, their immunomodulatory properties were assessed by analyzing their effect on the transcription of cytokines related to Th1 and Th2 responses. GT and MA, alone and in combination, were also assessed for their potential to alter metacaspase gene expression in L. major promastigotes by real-time RT-PCR. The hemolytic potential of GT and MA-treated promastigotes were also measured by routine UV absorbance reading. Electrophoresis on agarose gel was employed to analyze genomic DNA fragmentation. GT demonstrated notable dose-dependent antileishmanial effects towards promastigotes and amastigotes of L. major. The IC The results demonstrated that GT showed potent activity against L. major stages. It seems that its mechanism of action involves representing an immunomodulatory role towards upregulation of iNOS and JAK-1, while downregulation of IL-10 and TGF- β. Moreover, GT has an antioxidative potential and exerts its action through activating macrophages to kill the organism. Further in vivo and clinical studies are essential to explore its effect in future programs.
Identifiants
pubmed: 35472413
pii: S0009-2797(22)00162-4
doi: 10.1016/j.cbi.2022.109957
pii:
doi:
Substances chimiques
Antioxidants
0
Antiprotozoal Agents
0
Cyclohexane Monoterpenes
0
Reactive Oxygen Species
0
Interleukin-10
130068-27-8
gamma-terpinene
4YGF4PQP49
Meglumine Antimoniate
75G4TW236W
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
109957Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.